Ostatní
Návod 
Protagonist Therapeutics, Inc.
PTGX
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
5.1B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
7%
ROA
7%
PE
-48
PS
137
Cena 1R
34-97
⌀ Cena
63.57
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
18-03-2026
Poslední dividenda
Profil
Protagonist Therapeutics, Inc., biofarmaceutická společnost, objevuje a vyvíjí léčivé přípravky na bázi peptidů, které se zabývají hematologií a poruchami krve a zánětlivými a imunomodulačními onemocněními. Vyvíjí se rusfertid (PTG- 300), injekčně podávané hepcidinové mimetikum, které je součástí klinických studií fáze II pro léčbu pacientů s polycythemií vera a dědičnou hemochromatózou, stejně jako pro léčbu jiných poruch krve; PN- 943, perorální, alfa- 4- beta- 7 integrin-specifický antagonistický peptid, který je součástí klinických studií fáze II pro léčbu zánětlivého onemocnění střev (IBD); a PN- 235, podávaný perorálně antagonista receptoru pro leukin- 23 k léčbě IBD a non-IBD indikací. Společnost má licenční smlouvu a smlouvu o spolupráci s Janssen Biotech, Inc. Protagonist Therapeutics, Inc. byla založena v roce 2006 a sídlí v Newarku v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
124
Založení
2016-08-11
Podobné společnosti
$ 87.47
+ $ 0.92
$ 32.49
- $ 0.40
$ 30.13
- $ 2.12
$ 54.12
+ $ 0.08
$ 59.70
+ $ 1.04
$ 23.05
- $ 0.30
$ 36.93
+ $ 0.16
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 46.0 | 46.0 | 434.4 | 60.0 | 26.6 | 27.4 | 28.6 | 0.2 | 30.9 | 20.1 | 0.0 | 0.0 | 0.0 | |
| Cost of Revenues | 0.4 | 1.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 45.6 | 44.8 | 434.4 | 60.0 | 26.6 | 27.4 | 28.6 | 0.2 | 30.9 | 20.1 | 0.0 | 0.0 | 0.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 7.4 | 4.7 | 5.5 | 28.3 | 170.6 | 4.7 | 4.2 | 255.0 | 60.0 | 0.0 | |
| Cost of Revenues | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | 0.8 | |
| Gross Profit | 7.1 | 4.7 | 5.5 | 28.3 | 170.6 | 4.7 | 4.2 | 255.0 | 59.2 | -0.8 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 120.2 | 126.2 | 126.0 | 74.5 | 65.0 | 59.5 | 46.2 | 25.7 | 11.8 | 7.5 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 33.5 | 31.7 | 27.2 | 18.6 | 15.7 | 13.7 | 11.8 | 7.0 | 3.0 | 1.9 | |
| Depreciation & Amortization | 1.3 | 1.2 | 0.8 | 3.3 | 3.4 | 0.3 | 0.9 | 2.8 | 0.5 | 0.4 | 0.3 | 0.2 | 0.3 | |
| Total Operating Expenses | 203.8 | 202.9 | 181.6 | 153.7 | 158.0 | 153.2 | 93.1 | 80.8 | 73.2 | 58.0 | 32.7 | 14.8 | 9.3 | |
| Operating Income | -158.1 | -158.1 | 252.8 | -93.7 | -131.4 | -125.8 | -64.5 | -80.5 | -42.3 | -37.9 | -32.7 | -14.8 | -9.3 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 28.9 | 30.7 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.1 | 7.7 | ||
| Depreciation & Amortization | 0.4 | 0.4 | 0.3 | 0.2 | 0.5 | 0.6 | 1.5 | 0.2 | 0.8 | 0.8 | ||
| Total Operating Expenses | 57.4 | 51.1 | 47.6 | 47.6 | 43.9 | 46.1 | 43.0 | 48.6 | 37.0 | 38.3 | ||
| Operating Income | -50.4 | -46.4 | -42.0 | -19.3 | 126.8 | -41.5 | -38.8 | 206.3 | 23.0 | -38.3 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 28.8 | 28.8 | 26.3 | 14.9 | 4.1 | 0.4 | 0.9 | 2.8 | 2.5 | 0.9 | 0.2 | 0.0 | 0.0 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | -3.4 | 0.0 | 0.6 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | 28.8 | 28.8 | 26.6 | 14.7 | 4.0 | 0.3 | -0.3 | 2.6 | 2.5 | 0.9 | -4.8 | -0.1 | -1.8 | |
| IBT | -129.3 | -129.3 | 279.4 | -79.0 | -127.4 | -125.6 | -64.8 | -77.9 | -39.7 | -37.0 | -37.2 | -14.9 | -11.1 | |
| Income Tax Expense | 0.8 | 0.8 | 4.2 | 0.0 | -4.0 | -2.9 | 1.3 | -0.7 | -0.8 | -0.4 | 4.2 | 0.1 | 1.8 | |
| Net Income | -130.1 | -130.1 | 275.2 | -79.0 | -123.4 | -122.6 | -66.2 | -77.2 | -38.9 | -37.0 | -37.2 | -14.9 | -11.1 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 6.8 | 7.0 | 7.4 | 7.6 | 6.9 | 7.7 | 7.4 | 4.4 | 4.2 | 4.3 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.3 | 0.0 | ||
| Other Expense | 6.6 | 7.1 | 7.4 | 7.7 | 6.9 | 7.8 | 7.5 | 4.4 | 4.3 | 4.2 | ||
| IBT | -43.7 | -39.3 | -34.6 | -11.7 | 133.7 | -33.6 | -31.3 | 210.7 | 27.3 | -34.1 | ||
| Income Tax Expense | 0.7 | 0.0 | 0.2 | 0.0 | 2.0 | -0.4 | -0.7 | 3.3 | -4.2 | -0.8 | ||
| Net Income | -44.4 | -39.3 | -34.8 | -11.7 | 131.7 | -33.2 | -30.6 | 207.3 | 27.3 | -34.1 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-1.39 | $-2.52 | $-2.65 | $-1.92 | $-2.98 | $-1.74 | $-2.09 | $-5.72 | $-2.52 | $-1.88 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-1.39 | $-2.52 | $-2.65 | $-1.92 | $-2.98 | $-1.74 | $-2.09 | $-5.72 | $-2.52 | $-1.88 | |
| Shares Outstanding | 63.6 | 63.6 | 61.6 | 56.8 | 49.0 | 46.3 | 34.4 | 25.9 | 22.4 | 17.7 | 6.5 | 5.9 | 5.9 | |
| Diluted Shares Outstanding | 63.6 | 63.6 | 65.1 | 56.8 | 49.0 | 46.3 | 34.4 | 25.9 | 22.4 | 17.7 | 6.5 | 5.9 | 5.9 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.45 | $-0.58 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.44 | $-0.58 | ||
| Shares Outstanding | 63.6 | 63.8 | 63.5 | 63.0 | 62.3 | 61.8 | 61.3 | 60.9 | 60.4 | 59.2 | ||
| Diluted Shares Outstanding | 63.6 | 63.8 | 63.5 | 63.0 | 66.4 | 61.8 | 61.3 | 63.6 | 61.8 | 59.2 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 355.6 | 97.2 | 186.7 | 125.7 | 123.7 | 117.4 | 33.0 | 82.2 | 106.0 | 21.1 | 4.1 | 9.3 | |
| Short Term Investments | 208.4 | 321.7 | 154.9 | 111.6 | 203.2 | 188.5 | 100.0 | 46.6 | 38.0 | 56.5 | 7.9 | 0.0 | |
| Total Cash & ST Investments | 564.0 | 418.9 | 341.6 | 237.4 | 326.9 | 307.8 | 133.0 | 128.9 | 155.5 | 87.7 | 11.9 | 9.3 | |
| Accounts Receivable | 1.4 | 168.5 | 10.3 | 0.1 | 4.4 | 3.5 | 6.8 | 6.0 | 3.2 | 2.2 | 0.7 | 0.5 | |
| Inventory | 0.0 | 0.0 | 0.0 | -0.1 | 8.5 | 4.0 | 4.8 | 2.1 | -8.7 | -7.7 | 1.3 | 0.0 | |
| Other Current Assets | 5.6 | 4.2 | 3.6 | 0.0 | 1.0 | 0.3 | 0.7 | 0.5 | 1.1 | 0.9 | 0.3 | 0.1 | |
| Total Current Assets | 570.9 | 591.6 | 355.6 | 237.4 | 340.7 | 315.6 | 145.3 | 137.5 | 150.9 | 83.2 | 14.2 | 9.9 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 113.7 | 168.5 | 139.7 | 97.2 | 131.1 | 355.6 | 172.6 | 186.7 | 230.5 | 235.4 | |
| Short Term Investments | 462.4 | 401.9 | 434.7 | 321.7 | 337.6 | 208.4 | 150.1 | 154.9 | 90.2 | 78.0 | |
| Total Cash & ST Investments | 576.1 | 570.5 | 574.4 | 418.9 | 468.7 | 564.0 | 322.6 | 341.6 | 322.7 | 313.4 | |
| Accounts Receivable | 0.6 | 28.0 | 27.1 | 168.5 | 2.7 | 1.4 | 300.4 | 10.3 | 0.1 | 0.1 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.1 | -0.1 | |
| Other Current Assets | 9.7 | 4.1 | 4.4 | 4.2 | 5.4 | 5.6 | 4.5 | 3.6 | 4.1 | 3.5 | |
| Total Current Assets | 586.4 | 602.5 | 605.9 | 591.6 | 476.8 | 570.9 | 627.6 | 355.6 | 324.9 | 316.9 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 12.0 | 12.6 | 2.1 | 4.6 | 6.7 | 6.4 | 7.7 | 0.9 | 0.9 | 0.6 | 0.6 | 0.4 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 31.7 | 140.3 | 0.0 | 0.0 | 0.0 | 2.0 | 0.0 | 0.0 | 11.5 | 10.2 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.0 | 0.2 | 0.2 | 5.9 | 0.2 | 0.5 | 0.5 | 0.5 | 0.5 | 0.0 | 0.0 | 0.0 | |
| Total Long-Term Assets | 43.7 | 153.1 | 2.4 | 10.6 | 7.0 | 8.9 | 9.6 | 2.0 | 12.8 | 10.7 | 0.6 | 0.4 | |
| Total Assets | 614.6 | 744.7 | 358.0 | 247.9 | 347.7 | 324.5 | 154.9 | 139.5 | 163.7 | 94.0 | 14.8 | 10.3 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 12.3 | 12.7 | 12.5 | 12.6 | 12.3 | 12.0 | 1.5 | 2.1 | 2.9 | 3.3 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 102.7 | 102.5 | 123.5 | 140.3 | 114.6 | 31.4 | 0.0 | 0.2 | 2.0 | 0.2 | |
| Other Long-Term Assets | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.0 | |
| Total Long-Term Assets | 115.3 | 115.5 | 136.3 | 153.1 | 127.1 | 43.7 | 1.7 | 2.4 | 5.1 | 3.5 | |
| Total Assets | 701.7 | 718.0 | 742.1 | 744.7 | 603.9 | 614.6 | 629.3 | 358.0 | 330.0 | 320.5 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 3.6 | 1.6 | 0.8 | 3.6 | 1.6 | 3.1 | 2.8 | 5.7 | 1.3 | 1.2 | 1.2 | 0.3 | |
| Short-Term Debt | 2.7 | 0.5 | 2.3 | 2.5 | 2.2 | 1.5 | 1.3 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 15.2 | 23.7 | 18.2 | 25.0 | 38.6 | 21.2 | -10.2 | 11.2 | 9.5 | 5.3 | 1.9 | 1.0 | |
| Current Liabilities | 41.6 | 47.4 | 21.3 | 31.2 | 44.0 | 40.2 | 35.4 | 26.2 | 42.6 | 6.4 | 3.1 | 1.4 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 5.6 | 3.2 | 2.9 | 1.6 | 3.0 | 3.6 | 3.5 | 0.8 | 1.3 | 4.6 | |
| Short-Term Debt | 2.2 | 2.2 | 1.6 | 0.5 | 0.0 | 0.0 | 0.5 | 2.3 | 3.6 | 4.9 | |
| Other Current Liabilities | 37.1 | 15.4 | 11.8 | 23.7 | 20.7 | 15.2 | 16.5 | 18.2 | 23.0 | 16.9 | |
| Current Liabilities | 44.9 | 35.5 | 35.1 | 47.4 | 44.6 | 41.6 | 39.9 | 21.3 | 27.9 | 26.4 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 11.0 | 10.4 | 0.0 | 1.1 | 3.7 | 4.5 | 15.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 11.0 | 10.9 | 1.1 | 3.7 | 5.9 | 6.0 | 7.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | -20.8 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 73.3 | 69.4 | 21.3 | 784.7 | 47.7 | 44.9 | 75.0 | 27.0 | 43.1 | 6.4 | 5.2 | 2.4 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 8.5 | 9.1 | 9.8 | 10.4 | 10.9 | 11.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 10.7 | 11.3 | 11.4 | 10.9 | 10.9 | 11.0 | 0.5 | 1.1 | 1.8 | 2.4 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | |
| Total Liabilities | 56.3 | 50.0 | 53.1 | 69.4 | 71.9 | 73.3 | 68.8 | 21.3 | 27.9 | 26.4 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -247.2 | -0.9 | -0.7 | |
| Retained Earnings | -439.0 | -340.5 | -615.7 | -536.8 | -409.4 | -283.8 | -217.7 | -140.5 | -101.6 | -64.6 | -27.4 | -12.6 | |
| Comprehensive Income | -0.2 | -0.1 | -0.1 | -0.4 | -0.3 | 0.0 | -0.2 | -0.2 | 0.0 | -0.2 | -0.1 | -0.1 | |
| Total Common Equity | 541.3 | 675.3 | 336.7 | -536.8 | -409.4 | -283.8 | -217.7 | -140.5 | -101.6 | -64.6 | 9.6 | 8.0 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -426.3 | -386.9 | -352.2 | -340.5 | -472.2 | -439.0 | -408.4 | -615.7 | -643.0 | -608.9 | |
| Comprehensive Income | 0.5 | 0.0 | 0.1 | -0.1 | 1.3 | -0.2 | -0.2 | -0.1 | -0.2 | -0.2 | |
| Total Common Equity | 645.4 | 668.0 | 689.1 | 675.3 | 531.9 | 541.3 | 560.4 | 336.7 | -643.0 | 294.1 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 11.0 | 10.9 | 1.1 | 3.7 | 5.9 | 6.0 | 17.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 541.3 | 675.3 | 336.7 | -536.8 | 300.0 | 279.6 | 80.0 | 112.5 | 120.6 | 87.6 | 9.6 | 8.0 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 645.4 | 668.0 | 689.1 | 675.3 | 531.9 | 541.3 | 560.4 | 336.7 | -643.0 | 294.1 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 170.0 | 0.0 | 275.2 | -79.0 | -127.4 | -125.6 | -66.2 | -77.2 | -38.9 | -37.0 | -37.2 | -14.9 | -11.1 | |
| Depreciation & Amortization | 3.4 | 0.0 | 2.9 | 3.3 | 3.4 | 2.8 | 2.6 | 2.5 | 0.5 | 0.4 | 0.3 | 0.2 | 0.3 | |
| Stock-Based Compensation | 31.7 | 46.0 | 37.6 | 29.3 | 24.2 | 16.4 | 7.9 | 8.4 | 6.9 | 4.2 | 2.1 | 0.1 | 0.0 | |
| Change Working Capital | 32.2 | 146.2 | -122.6 | -19.5 | -7.8 | -3.3 | -19.0 | 26.1 | -18.0 | 35.6 | -0.1 | 0.1 | 1.3 | |
| Change In Accounts Receivable | 0.0 | 164.9 | -155.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.8 | -1.8 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | -1.2 | 3.7 | 0.8 | -2.9 | 2.0 | -1.4 | 0.3 | -3.0 | 4.4 | 0.1 | -0.1 | 0.9 | 0.2 | |
| Change In Inventories | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.9 | 5.5 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 10.3 | -134.5 | -8.9 | -4.4 | -0.5 | 1.8 | 0.8 | -0.6 | 0.2 | 0.6 | 4.7 | 0.1 | 1.8 | |
| Cash from Operations | 231.5 | 0.0 | 0.0 | -70.2 | -108.1 | -107.9 | -72.5 | -41.5 | -49.9 | 3.9 | -30.0 | -14.4 | -7.7 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 85.8 | -39.3 | -34.8 | -11.7 | 131.7 | -33.2 | -30.6 | 207.3 | 27.3 | -34.1 | |
| Depreciation & Amortization | -0.9 | 0.4 | 0.3 | 0.2 | 0.5 | 0.6 | 0.9 | 0.8 | 0.8 | 0.8 | |
| Stock-Based Compensation | 10.7 | 0.0 | 10.9 | 13.8 | 9.1 | 0.0 | 0.0 | 0.0 | 6.6 | 6.8 | |
| Change Working Capital | -2.7 | 28.1 | -3.9 | 124.7 | -167.7 | -2.6 | 291.1 | -243.3 | -16.5 | 0.9 | |
| Change In Accounts Receivable | 0.5 | -0.6 | 0.5 | 165.0 | -165.0 | 0.0 | 300.0 | -290.0 | -10.0 | 0.0 | |
| Change In Accounts Payable | -0.3 | 2.4 | 0.4 | 1.2 | -1.4 | -0.4 | -0.2 | 2.8 | -0.6 | -3.2 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.0 | 0.0 | |
| Other Non-cash Items | -129.9 | 9.0 | -1.3 | -1.7 | -2.8 | 7.3 | 7.3 | 7.7 | -1.3 | 5.8 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 17.0 | -26.6 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.7 | -1.6 | -1.4 | -0.6 | -0.8 | -1.1 | -0.5 | -1.0 | -0.5 | -0.7 | -0.4 | -0.4 | -0.3 | |
| Acquisitions | 74.4 | 0.0 | 0.0 | 0.0 | -91.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -397.6 | -546.6 | -621.7 | -191.0 | -214.9 | -286.6 | -280.0 | -166.9 | -71.1 | -39.5 | -73.2 | -7.9 | 0.0 | |
| Sales of Investment | 241.3 | 498.8 | 323.6 | 152.4 | 307.1 | 271.8 | 189.5 | 114.2 | 73.8 | 56.0 | 14.2 | 0.0 | 0.0 | |
| Other Investing Activities | -156.2 | 0.0 | 0.0 | 0.0 | 91.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -156.9 | 0.0 | 0.0 | -39.3 | 91.5 | -15.9 | -91.0 | -53.7 | 2.2 | 15.8 | -59.3 | -8.3 | -0.3 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 1.4 | -0.1 | -0.8 | -0.5 | -0.3 | -0.8 | 0.0 | -0.2 | 0.0 | -0.4 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 61.3 | 13.2 | |
| Investments | 442.3 | -161.1 | -67.2 | -214.0 | -114.4 | -266.7 | -175.0 | -65.7 | -98.0 | -59.0 | |
| Sales of Investment | -345.6 | 102.7 | 122.8 | 120.2 | 106.0 | 58.7 | 86.9 | 72.0 | 36.7 | 45.8 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -61.3 | -13.2 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -61.3 | -13.6 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -10.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 8.5 | 10.9 | 9.7 | -2.5 | -2.2 | -0.1 | -0.5 | 17.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 46.2 | 0.0 | 0.0 | 132.1 | 14.6 | 123.8 | 255.4 | 34.5 | 23.2 | 64.5 | 83.6 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 37.8 | 0.0 | 0.0 | 38.4 | 4.3 | 6.1 | 2.8 | 11.5 | 0.9 | 1.0 | 22.7 | 17.4 | 9.0 | |
| Cash from Financing | 45.6 | 0.0 | 0.0 | 170.5 | 18.8 | 129.9 | 247.6 | 46.0 | 24.1 | 65.6 | 106.3 | 17.4 | 9.0 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 10.7 | -0.5 | -0.1 | 0.5 | 0.0 | -0.1 | 10.5 | -0.7 | -0.7 | -0.6 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 35.3 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 35.3 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 120.3 | 31.1 | -89.5 | 61.0 | 2.1 | 6.1 | 84.4 | -49.2 | -23.8 | 85.4 | 17.0 | -5.3 | 0.9 | |
| Closing Cash Balance | 355.6 | 128.4 | 97.5 | 187.0 | 126.0 | 123.9 | 117.8 | 33.5 | 82.7 | 106.5 | 21.1 | 4.1 | 9.3 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 14.7 | -54.8 | 29.0 | 42.4 | -33.9 | -224.5 | 183.1 | -14.2 | -43.8 | -4.9 | |
| Closing Cash Balance | 128.4 | 113.7 | 168.8 | 139.7 | 97.5 | 131.1 | 355.6 | 172.6 | 187.0 | 230.8 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 230.8 | 56.1 | 182.8 | -70.8 | -108.9 | -109.0 | -73.0 | -42.5 | -50.4 | 3.2 | -30.4 | -14.8 | -8.0 | |
| Real Free Cash Flow | 199.2 | 10.1 | 145.2 | -100.1 | -133.1 | -125.4 | -80.9 | -50.8 | -57.4 | -1.0 | -32.5 | -14.9 | -8.1 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -35.5 | -2.0 | -29.6 | 124.8 | -29.5 | -28.6 | 268.6 | -27.7 | 16.9 | -27.0 | |
| Real Free Cash Flow | -46.2 | -2.0 | -40.5 | 111.0 | -38.6 | -28.6 | 268.6 | -27.7 | 10.3 | -33.8 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -48.3 | 2 | -1.4 |
| P/S | 136.6 | 30.5 | 9.4 |
| P/B | 9.7 | 3.7 | 5.2 |
| P/FCF | 282.4 | -18.3 | -1.5 |
| Market cap | $5.1 | $17.7 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 1.5 % | 1.7 % | 0 % |
| Debt to Income | -8.3 % | -1.8 % | 0 % |
| Debt to Free cash flow | 48.3 % | -1594.2 % | 0 % |
| Interest expense percentage | 0 % | 0.2 % | 44.7 % |
| Current ratio | 13 | 7.9 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -20.2 % | -21 % | 0 % |
| ROA | -18.5 % | -30.5 % | 0 % |
| CapEx to Revenue | 0.8 % | 1 % | 0 % |
| RaD to Revenue | 0 % | 169.1 % | 0 % |
| ROEM | 365,206.3 | 226350.9 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 100 % | 71.2 % | 68.7 % |
| Operating margin | 9.1 % | -148.2 % | 35.5 % |
| Net margin | 21.9 % | -155.2 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 63.8 mil | 34.7 mil |
| Employee count | 0.1 tis | 0.1 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
